{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T21:44:38Z","timestamp":1748641478419},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.rvsc.2024.105271","type":"journal-article","created":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T01:41:55Z","timestamp":1713058915000},"page":"105271","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety of an oral combination of moxidectin, afoxolaner, and pyrantel pamoate in dogs"],"prefix":"10.1016","volume":"173","author":[{"given":"Marlene","family":"Drag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Tielemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norba","family":"Targa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Bruner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Colley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Becky","family":"Fankhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.rvsc.2024.105271_bb0005","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1007\/s00436-005-1448-x","article-title":"Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs","volume":"97","author":"Arther","year":"2005","journal-title":"Parasitol. Res."},{"issue":"12","key":"10.1016\/j.rvsc.2024.105271_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpara.2008.03.002","article-title":"Combined ivermectin and doxycycline treatment has microfilaricidal and adulticidal activity against Dirofilaria immitis in experimentally infected dogs","volume":"38","author":"Bazzocchi","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.rvsc.2024.105271_bb0015","series-title":"Recent Advances in Heartworm Disease: Symposium \u201801","first-page":"159","article-title":"Safety of moxidectin canine SR (sustained release) injectable in ivermectin-sensitive Collies and in naturally infected mongrel dogs","author":"Blagburn","year":"2001"},{"issue":"10","key":"10.1016\/j.rvsc.2024.105271_bb0020","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1172\/JCI70430","article-title":"P-glycoprotein ABCB1: a major player in drug handling by mammals","volume":"123","author":"Borst","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.rvsc.2024.105271_bb0025","first-page":"767","article-title":"Evaluation of pyrantel hydrochloride as an anthelmintic in dogs","volume":"65","author":"Bradley","year":"1970","journal-title":"Vet. Med. Small Anim. Clin."},{"issue":"1","key":"10.1016\/j.rvsc.2024.105271_bb0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12917-017-1251-9","article-title":"Frequency of canine nt230(del4) ABCB1 mutation in prone pure breeds, their crosses and mongrels in Israel - insights from a worldwide comparative perspective","volume":"13","author":"Dekel","year":"2017","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.rvsc.2024.105271_bb0035","series-title":"15th Triennial Heartworm Symposium. September 11\u201313, 2016","article-title":"Cardiopulmonary effects of D. Immitis byproducts in circulation in dogs, cats, and rats","author":"Dillon","year":"2016"},{"key":"10.1016\/j.rvsc.2024.105271_bb0040","doi-asserted-by":"crossref","unstructured":"Drag M, Saik J, Harriman J, Larsen D. 2014. Safety evaluation of orally administered afoxolaner in 8-week-old dogs. Vet. Parasitol., 201(3\u20134), 198\u2013203. dio: https:\/\/doi.org\/10.1016\/j.vetpar.2014.02.022.","DOI":"10.1016\/j.vetpar.2014.02.022"},{"issue":"5","key":"10.1016\/j.rvsc.2024.105271_bb0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/jvp.12375","article-title":"Safety evaluation of orally administered afoxolaner and milbemycin oxime in eight-week-old dogs","volume":"40","author":"Drag","year":"2017","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.rvsc.2024.105271_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jvp.13064","article-title":"Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1 deficient collie dogs","volume":"45","author":"Drag","year":"2022","journal-title":"J. Vet. Pharma Thera."},{"key":"10.1016\/j.rvsc.2024.105271_bb0055","series-title":"CVMP Scientific discussion for Advocate (EMEA\/V\/C\/000076)","author":"EMA","year":"2009"},{"key":"10.1016\/j.rvsc.2024.105271_bb0060","series-title":"CVMP assessment report for NexGard (EMEA\/V\/C\/002729)","author":"EMA","year":"2013"},{"key":"10.1016\/j.rvsc.2024.105271_bb0065","series-title":"CVMP assessment report for NexGard Spectra (EMEA\/V\/C\/003842)","author":"EMA","year":"2014"},{"key":"10.1016\/j.rvsc.2024.105271_bb0070","series-title":"CVMP Scientific discussion for Simparica Trio (EMEA\/V\/C\/004846)","author":"EMA","year":"2021"},{"key":"10.1016\/j.rvsc.2024.105271_bb0075","series-title":"Freedom of Information Summary, NADA 141\u2013251","author":"FDA","year":"2006"},{"key":"10.1016\/j.rvsc.2024.105271_bb0080","author":"FDA"},{"key":"10.1016\/j.rvsc.2024.105271_bb0085","author":"FDA"},{"issue":"9","key":"10.1016\/j.rvsc.2024.105271_bb0090","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2460\/javma.252.9.1084","article-title":"Effects of milbemycin oxime, combined with spinosad, when administered orally to microfilaremic dogs infected with adult heartworms (Dirofilaria immitis)","volume":"252","author":"Grant","year":"2018","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"10 Spec","key":"10.1016\/j.rvsc.2024.105271_bb0095","first-page":"1170","article-title":"Levamisole in dirofilariasis of dogs","volume":"176","author":"Jackson","year":"1980","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.rvsc.2024.105271_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.702018","article-title":"An accessible alternative to Melarsomine: \u201cMoxi-doxy\u201d for treatment of adult heartworm infection in dogs","volume":"8","author":"Jacobson","year":"2021","journal-title":"Front. Vet. Sci."},{"issue":"2","key":"10.1016\/j.rvsc.2024.105271_bb0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2165\/00003495-197713020-00002","article-title":"Anthelmintics","volume":"13","author":"Katz","year":"1977","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.rvsc.2024.105271_bb0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s13071-019-3690-6","article-title":"Safety of an extended-release injectable moxidectin suspension formulation (ProHeart\u00ae 12) in dogs","volume":"12","author":"Krautmann","year":"2019","journal-title":"Parasit. Vectors"},{"issue":"1","key":"10.1016\/j.rvsc.2024.105271_bb0115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s13071-019-3702-6","article-title":"Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs","volume":"12","author":"Kryda","year":"2019","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.rvsc.2024.105271_bb0120","series-title":"Recent Advances in Heartworm Disease: Symposium \u201801","first-page":"149","article-title":"Six-month prophylactic efficacy of an injectable formulation against Dirofilaria immitis infection: A two-center study","author":"Lok","year":"2001"},{"issue":"1","key":"10.1016\/j.rvsc.2024.105271_bb0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pt.2020.10.005","article-title":"Ivermectin: An Anthelmintic, an Insecticide, and Much More","volume":"37","author":"Martin","year":"2021","journal-title":"Trends Parasitol."},{"issue":"2\u20133","key":"10.1016\/j.rvsc.2024.105271_bb0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.vetpar.2005.04.005","article-title":"The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations","volume":"133","author":"McCall","year":"2005","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.rvsc.2024.105271_bb0135","series-title":"Recent Advances in Heartworm Disease: Symposium \u201801","first-page":"169","article-title":"Prevention of naturally acquired heartworm infection in heartworm-na\u00efve Beagles by oral administration of moxidectin at an interval of either one or two months","author":"McCall","year":"1992"},{"key":"10.1016\/j.rvsc.2024.105271_bb0140","series-title":"Recent Advances in Heartworm Disease: Symposium \u201801","first-page":"165","article-title":"Evaluation of retroactive and adulticidal activity of moxidectin canine SR (sustained release) injectable formulation against Dirofilaria immitis in Beagles","author":"McCall","year":"2001"},{"issue":"3","key":"10.1016\/j.rvsc.2024.105271_bb0145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.vetpar.2008.09.008","article-title":"Heartworm and Wolbachia: therapeutic implications","volume":"158","author":"McCall","year":"2008","journal-title":"Vet. Parasitol."},{"issue":"1\u20132","key":"10.1016\/j.rvsc.2024.105271_bb0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vetpar.2014.09.011","article-title":"Safety and efficacy of 10% imidacloprid+2.5% moxidectin for the treatment of Dirofilaria immitis circulating microfilariae in experimentally infected dogs","volume":"206","author":"McCall","year":"2014","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.rvsc.2024.105271_bb0155","series-title":"Proceedings of the Heartworm Symposium \u201892","first-page":"165","article-title":"Prevention of experimental heartworm infection in dogs with single, oral doses of moxidectin","author":"McTier","year":"1992"},{"issue":"Suppl. 2","key":"10.1016\/j.rvsc.2024.105271_bb0160","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s13071-017-2429-5","article-title":"Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs","volume":"10","author":"McTier","year":"2017","journal-title":"Parasit. Vectors"},{"issue":"3","key":"10.1016\/j.rvsc.2024.105271_bb0165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetpar.2008.09.009","article-title":"(2008). Canine ABCB1 and macrocyclic lactones: heartworm prevention and pharmacogenetics","volume":"158","author":"Mealey","year":"2008","journal-title":"Vet. Parasitol."},{"issue":"6","key":"10.1016\/j.rvsc.2024.105271_bb0170","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2460\/javma.233.6.921","article-title":"(2008). Breed distribution of the ABCB1-1Delta (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping","volume":"233","author":"Mealey","year":"2008","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"8","key":"10.1016\/j.rvsc.2024.105271_bb0175","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00008571-200111000-00012","article-title":"(2001). Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene","volume":"11","author":"Mealey","year":"2001","journal-title":"Pharmacogenetics"},{"issue":"3\u20134","key":"10.1016\/j.rvsc.2024.105271_bb0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.vetpar.2015.02.036","article-title":"Acute phase protein response in heartworm-infected dogs after adulticide treatment","volume":"209","author":"M\u00e9ndez","year":"2015","journal-title":"Vet. Parasitol."},{"issue":"2","key":"10.1016\/j.rvsc.2024.105271_bb0185","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cvsm.2011.12.005","article-title":"Toxicology of Avermectins and Milbemycins (Macrocylic lactones) and the role of P-glycoprotein in dogs and cats","volume":"42","author":"Merola","year":"2012","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"issue":"6","key":"10.1016\/j.rvsc.2024.105271_bb0190","first-page":"111","article-title":"Frequency of the MDR1 mutant allele associated with multidrug sensitivity in dogs from Brazil","volume":"2015","author":"Monobe","year":"2015","journal-title":"Vet. Med. (Auckl)."},{"issue":"32","key":"10.1016\/j.rvsc.2024.105271_bb0195","doi-asserted-by":"crossref","first-page":"11725","DOI":"10.1073\/pnas.0402374101","article-title":"Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage","volume":"101","author":"Neff","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.rvsc.2024.105271_bb0200","first-page":"354","article-title":"Ivermectin toxicity in an Australian shepherd dog with the MDR1 mutation associated with ivermectin sensitivity in collies","volume":"17","author":"Nelson","year":"2003","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.rvsc.2024.105271_bb0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpddr.2021.03.004","article-title":"Heartworm disease - overview, intervention, and industry perspective","volume":"16","author":"Noack","year":"2021","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.rvsc.2024.105271_bb0210","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2460\/ajvr.2000.61.482","article-title":"Safety of moxidectin in avermectin-sensitive collies","volume":"61","author":"Paul","year":"2000","journal-title":"Am. J. Vet. Res."},{"issue":"3\u20134","key":"10.1016\/j.rvsc.2024.105271_bb0215","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.vetpar.2004.03.005","article-title":"Dermal safety study with imidacloprid\/moxidectin topical solution in the ivermectin-sensitive collie","volume":"121","author":"Paul","year":"2004","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.rvsc.2024.105271_bb0220","series-title":"Veterinary handbook","first-page":"3078","author":"Plumb'\u2019s","year":"2011"},{"issue":"1","key":"10.1016\/j.rvsc.2024.105271_bb0225","first-page":"221","article-title":"Surgical transplantation of adult Dirofilaria immitis to study heartworm infection and disease in dogs","volume":"46","author":"Rawlings","year":"1985","journal-title":"Am. J. Vet. Res."},{"issue":"4","key":"10.1016\/j.rvsc.2024.105271_bb0230","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1292\/jvms1939.51.711","article-title":"Prevention of adverse reactions following milbemycin D administration to microfilaremic dogs infected with Dirofilaria immitis","volume":"51","author":"Sasaki","year":"1989","journal-title":"Nihon Juigaku Zasshi."},{"issue":"1","key":"10.1016\/j.rvsc.2024.105271_bb0235","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13071-017-2190-9","article-title":"Assessment of parasitological findings in heartworm-infected beagles treated with advantage multi\u00ae for dogs (10% imidacloprid+2.5% moxidectin) and doxycycline","volume":"10","author":"Savadelis","year":"2017","journal-title":"Parasit. Vectors"},{"issue":"1","key":"10.1016\/j.rvsc.2024.105271_bb0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13071-021-05104-7","article-title":"Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance","volume":"15","author":"Savadelis","year":"2022","journal-title":"Parasit. Vectors"},{"issue":"7","key":"10.1016\/j.rvsc.2024.105271_bb0245","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2460\/ajvr.1991.52.07.1170","article-title":"Assessment of toxicosis induced by high-dose administration of milbemycin oxime in collies","volume":"52","author":"Tranquilli","year":"1991","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.rvsc.2024.105271_bb0250","series-title":"Target Animal Safety - Pharmaceuticals: Target Animal Safety for Veterinary Pharmaceutical Products","author":"VICH Guideline GL 43","year":"2008"},{"issue":"3","key":"10.1016\/j.rvsc.2024.105271_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10158-016-0190-7","article-title":"How do the macrocyclic lactones kill filarial nematode larvae?","volume":"16","author":"Wolstenholme","year":"2016","journal-title":"Invertebr. Neurosci."},{"issue":"9","key":"10.1016\/j.rvsc.2024.105271_bb0260","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ijpara.2004.04.010","article-title":"An ivermectin-sensitive glutamate-gated chloride channel subunit from Dirofilaria immitis","volume":"34","author":"Yates","year":"2004","journal-title":"Int. J. Parasitol."}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528824001371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528824001371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:45:54Z","timestamp":1715820354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528824001371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":52,"alternative-id":["S0034528824001371"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2024.105271","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of an oral combination of moxidectin, afoxolaner, and pyrantel pamoate in dogs","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2024.105271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105271"}}